News & Breakthroughs at Siteman

Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.

In the Media News & Stories

In the Media

Promising role for whole genome sequencing in guiding blood cancer treatment

March 11, 2021

For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes. Some of these tests rely on technology that was invented more than 60 years ago and has been used clinically for the […]

Clinical, In the Media

Siteman Cancer Center named among top U.S. cancer centers

July 28, 2020

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine has been named among the top cancer centers nationally by U.S. News & World Report. The recognition is part of the overall ranking of Barnes-Jewish and Washington University, which are No. 18 on the news magazine’s 2020-21 “Best Hospitals” list, released today. Siteman […]

In the Media

Siteman Cancer Center director, benefactor named 2019 citizens of the year

February 5, 2020

Two people who shared the vision to build what is now Siteman Cancer Center have been recognized as citizens of the year. Timothy J. Eberlein, MD, Siteman’s director, and Alvin J. Siteman, the benefactor for whom the center is named, were recognized by the St. Louis Post-Dispatch after being selected by a committee of past recipients. The honor, typically given […]

In the Media

Woman’s horse provides inspiration for her breast cancer journey

March 25, 2019

In the Media

Gamma Knife manager’s career combines nursing and law enforcement

January 4, 2019

In the Media

Phelps County Regional Medical Center joins Siteman Cancer Network

June 25, 2018

Phelps County Regional Medical Center and the hospital’s Delbert Day Cancer Institute have joined the Siteman Cancer Network to collaborate on efforts to reduce the impact of cancer in south-central Missouri through research, treatment and prevention. The network is affiliated with Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. […]

In the Media

Gift allows Siteman Cancer Center to establish resiliency program for nurses

June 22, 2018

A $500,000 donation to Washington University School of Medicine in St. Louis will be used to provide resiliency training for nurses at Siteman Cancer Center at Barnes-Jewish Hospital and the School of Medicine. The program will be aimed at improving care for them and, ultimately, their patients. The gift establishes the Josh Gottheil Memorial Endowment […]

In the Media

PECaD’s Manshack Appointed to New ACS Board of Directors

June 20, 2018

Lindsey Manshack, MPH, a member of Siteman Cancer Center’s Program for the Elimination of Cancer Disparities (PECaD), has been appointed to the American Cancer Society (ACS) Missouri Area Board of Directors. In this newly created position, Manshack will work with four other ACS board members to reduce cancer disparities in the Missouri region through creating awareness, fundraising and […]

In the Media

Jeffrey Bradley, MD, gives commencement address at Drury University

May 15, 2018

Jeffrey Bradley, MD, a Washington University radiation oncologist at Siteman Cancer Center, gave a commencement address to the graduating class of 2018 at Drury University in Springfield, MO on May 12th. Dr. Bradley, who is a 1989 graduate of Drury University, also received an honorary Doctor of Humane Letters degree at the ceremony. Read full […]

In the Media, Research

$5 million supports innovative breast cancer trial at Siteman

May 17, 2018

A $5 million grant from the Department of Defense will support research at Washington University School of Medicine in St. Louis aimed at improving breast cancer therapies. The study, which includes a clinical trial at Siteman Cancer Center at Barnes-Jewish Hospital and the School of Medicine, will focus on HER2-positive breast cancer. Such tumors are dotted with an overabundance […]

Page 13 of 15